Profilo
George Bennett Hodgin has founded a company called Biopharmaceutical Research Co. in 2017, where he currently holds the title of Chief Executive Officer & Director.
Posizioni attive di George Hodgin
Società | Posizione | Inizio |
---|---|---|
Biopharmaceutical Research Co.
Biopharmaceutical Research Co. Pharmaceuticals: OtherHealth Technology Biopharmaceutical Research Co. is a specialty pharmaceutical company that focuses on providing safe and effective options for treating patients with innovative cannabinoid therapeutics. The company is based in Castroville, CA. The company holds several DEA registrations across the entire value chain of cannabis and is pioneering the federally legal cannabis space in the USA. BRC has full DEA compliance for botanically derived cannabinoids and has developed proprietary poly-cannabinoids in titratable dosages that are soon to enter the clinic. The company was founded in 2017 by George Bennett Hodgin, who has been the CEO since 2017. | Fondatore | 01/01/2017 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Biopharmaceutical Research Co.
Biopharmaceutical Research Co. Pharmaceuticals: OtherHealth Technology Biopharmaceutical Research Co. is a specialty pharmaceutical company that focuses on providing safe and effective options for treating patients with innovative cannabinoid therapeutics. The company is based in Castroville, CA. The company holds several DEA registrations across the entire value chain of cannabis and is pioneering the federally legal cannabis space in the USA. BRC has full DEA compliance for botanically derived cannabinoids and has developed proprietary poly-cannabinoids in titratable dosages that are soon to enter the clinic. The company was founded in 2017 by George Bennett Hodgin, who has been the CEO since 2017. | Health Technology |
- Borsa valori
- Insiders
- George Hodgin